Skip to main content
. 2021 Mar 4;16(3):e0247358. doi: 10.1371/journal.pone.0247358

Table 1. Descriptive statistics of patients at baseline.

Original data, i.e., available case analysis.

Variable n (%)
Age < 60 3,438 (38.1)
60–79 5,044 (56.0)
80+ 531 (5.9)
Sex Male 6,757 (75.0)
Low bodyweight (< 60 kg) - 381 (4.3)
Missing 172
Chronic kidney disease - 790 (9.2)
Missing 423
Diabetes mellitus - 1,123 (12.5)
Missing 25
Hypertension - 3,791 (42.4)
Missing 67
Hyperlipidemia - 4,868 (54.8)
Missing 135
Current, daily smoking - 3,147 (38.1)
Missing 758
Prior CABG - 593 (6.6)
Prior stroke - 346 (3.8)
Missing 14
Prior MI - 912 (10.2)
Missing 45
Current ACS - 6,319 (70.2)
Missing 14
Multivessel disease - 3,574 (39.7)
Missing 5
Stent length < 20 mma 4,002 (44.4)
20–40 mm 3,311 (36.7)
≥ 40 mm 1,700 (18.9)
Stent diameter < 3 mma 2,945 (32.7)
3–4 mm 5,437 (60.3)
≥ 4 mm 630 (7.0)
Missing 1
Number of stents 1a 5,251 (58.3)
2 2,374 (26.3)
≥ 3 1,388 (15.4)

ACS: Acute coronary syndrome, CABG: Coronary artery bypass graft, CKD: Chronic kidney disease, MI: Myocardial infarction.

a 70 patients did not receive a stent after randomization and are included in this group.